Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Israel Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20082
20095
20102
20134
20142
20154
20161
20172
20182
20194
20201
20213
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting5
Recruiting4
Terminated4
Unknown status3
Withdrawn2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Can-Fite BioPharma3
Eli Lilly and Company3
Exelixis3
Merck Sharp & Dohme LLC3
AbbVie2
Mirror Biologics, Inc.2
Tel-Aviv Sourasky Medical Center2
Bristol-Myers Squibb1
CureTech Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular39
Liver Neoplasms8
Neoplasms7
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Non-Small-Cell Lung4
Fibrosis4
Triple Negative Breast Neoplasms4
Carcinoma, Renal Cell3
Ovarian Neoplasms3
Carcinoma2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.